Basiliximab (Systemic)
Brand Names : Simulect
Before Receiving This MedicineIn deciding to use a medicine, the risks of receiving the medicine must
be weighed against the good it will do. This is a decision you and your doctor
will make. For basiliximab, the following should be considered:
Allergies - Tell your doctor if you have ever had any unusual or
allergic reaction to proteins. Also tell your health care professional if
you are allergic to any other substances.
Pregnancy - Basiliximab crosses the placenta. However, basiliximab
has not been studied in pregnant women. Women of childbearing age are advised
to use contraception before receiving basiliximab. Use of the contraception
should continue until 2 months after treatment with basiliximab is completed.
Breast-feeding - It is not known if basiliximab passes into breast
milk. Patients receiving basiliximab should not breast-feed their babies.
Children - Studies on the use of basiliximab in children have
not been completed. Preliminary information on the use of basiliximab in children
suggests children have the same side effects from receiving basiliximab as
those experienced by adult patients, and basiliximab works as well to prevent
rejection of the transplanted kidney in children as it does in adult patients.
Older adults - Many medicines have not been studied specifically
in older people. Therefore, it may not be known whether they work exactly
the same way as they do in younger adults or if they cause different side
effects or problems in older people. There is no specific information comparing
use of basiliximab in the elderly with use in other age groups.
Other medicines - Tell your health care professional if you are
using any other prescription or nonprescription (over-the-counter [OTC]) medicine.
Other medical problems - The presence of other medical
problems may affect the use of basiliximab. Make sure you tell your doctor
if you have any other medical problems, especially:
-
Cancer - Basiliximab may make this condition worse
-
Infection - Basiliximab may decrease the body's ability to fight
infection
|